Consistency [Two-Stage / GS Designs]

posted by DavidManteigas – Portugal, 2016-10-11 13:25 (3531 d 02:10 ago) – Posting: # 16721
Views: 17,266

Hi all,

I get shocked sometimes with the lack of consistency in assessments of member states which should all follow the same guidelines and made their reviews according to the current opinions of the scientific groups of the EMA. I think this happens due to lack of training in regulatory reviews and "regulatory science" in general (in Portugal, almost all of the reviewers I know are "academic") and also due to lack of resources in some agencies to have qualified reviewers for each 'specialty'.
In some countries, I believe that as long as you got a favourable opinion from an ethics committee and regulatory approval for the trial, they will consider your trial "valid" regardless of the appopriateness of the design, statistical methodology and compliance with guidelines/recommendations for design & analysis.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
165 visitors (0 registered, 165 guests [including 12 identified bots]).
Forum time: 15:36 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5